Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Proteostasis Therapeutics, Inc.

TRADE

NASDAQ: PTITechnology / Application Software / India
1.91+0.15+8.52%Vol 165 9201Y Perf -8.17%
Oct 16th, 2018 16:00
BID1.77 ASK2.00
Open1.79 Previous Close1.76
Pre-Market- After-Trading1.91
 - -%  - -%
Target Price
15.33 
Analyst Rating
Moderate Buy 1.67
Potencial %
702.62 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★+     46.76
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)70 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
6.94 
Earnings Date
13th Nov 2018

Today's Price Range

1.791.98

 

52wk Range

1.418.61

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-14.35%
3 Months
-31.05%
6 Months
-63.96%
1 Year
-8.17%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
PTI1.910.15008.52
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 6.50
Current Ratio 6.70
Long Term Debt to Total Capital 0.20
Total Debt to Equity 0.26
Interest Coverage -
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-1 101.00
EBITDA Margin-1 087.90
Pre-tax Profit Margin-764.30
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.15
PS Ratios 19.06
Price to Cash Flow -
Price to Free Cash Flow -1.80
Cash Flow Per Share -1.62
Price to Tangible Book1.15
Book Value per Share1.54
Enterprise Value (in ths.)18 879
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)141.11
ROE last 12 Months -99.18
Return on Assets (5Y Avg) -44.82
ROA last 12 Months -75.39
Return on Capital (5Y Avg) -
ROC last 12 Months -79.61
Return on invested Capital Q -21.34
Return on invested Capital Y-80.00
Assets Turnover0.00
Receivables Turnover8.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)3 407
Revenue per Share 0.09
Revenue Growth 3 Years -0.67
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.41-0.43-4.88
Q01 2018-0.51-0.3237.25
Q04 2017-0.65-0.5121.54
Q03 2017-0.63-0.5611.11
Q02 2017-0.61-0.68-11.48
Q01 2017-0.58-0.60-3.45
Q04 2016-0.51-0.3825.49
Q03 2016-0.50-0.54-8.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.48-14.29Negative
12/2018 QR-0.50-19.05Negative
12/2018 FY-2.01-6.91Negative
12/2019 FY-2.11-9.90Negative
Next Report Date13th Nov 2018
Estimated EPS Next Report-0.48
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume165 920
Shares Outstanding (in ths.)36 700
Trades Count498
Dollar Volume282 001
Avg. Volume990 578
Avg. Weekly Volume134 779
Avg. Monthly Volume161 660
Avg. Quarterly Volume155 788

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

72%28%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x